Brief: Biosynex Buys Bigix Pharma In Italy
Sept 22 (Reuters) - BIOSYNEX SA ALBIO.PA :
* BUYS BIGIX PHARMA IN ITALY
* AIMS TO RAPIDLY DEVELOP ITS TURNOVER IN ITALY BY 2025
Source text for Eikon: ID:nEQ6DSHFba
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals